Vesalius Biocapital Partners and SRIW have led a €10m funding round in Belgian pharmaceuticals company Euroscreen.
Other investors in the round included Life Sciences Research Partners VZW, Societe de Participation et de Gestion, Hunza Ventures and existing shareholders Fortis Private Equity, Compagnie du Bois Sauvage,...
Deal sees firm reap combined €96.3m in proceeds and 1.3x exit multiple
SF-Filter's Germany head Jochen Zähringer will take over as CEO following buyout
Apax and GMG acquired the business for £1bn in 2008 when it was known as Emap
Duo acquired the stake at €66 price per share, representing a 18.1% premium